RAC 2.92% $1.94 race oncology ltd

Ann: Race raises $29.7 million in oversubscribed SPP, page-191

  1. 535 Posts.
    lightbulb Created with Sketch. 314
    Is it not possible to be hoping for a good investment outcome on our capital,
    while also hoping that Zantrene provides better prospects
    , better survival rates, and better health post treatment than
    current drugs and protocols provide?

    I know im hoping for both and i dont feel morally compromised
    by that.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.